Today: 19 November 2025
Subscribe
Browse Category

Biotech News 12 August 2025 - 25 August 2025

FDA Shockers, Breakthrough Trials & Outbreak Alerts – Biotech & Health News Roundup (Aug 24–25, 2025)

FDA Shockers, Breakthrough Trials & Outbreak Alerts – Biotech & Health News Roundup (Aug 24–25, 2025)

Regulatory Announcements: Approvals & Rejections Clinical Trial Breakthroughs & Research Highlights Industry Deals, Mergers & Investments Public Health Policy & Governance Updates Emerging Diseases & Vaccine News This comprehensive roundup highlights the fast-moving developments in biotech, pharma, and health over the past 48 hours. From life-saving drugs and high-stakes deals to public health challenges, the landscape is evolving daily. As always, readers are advised to consult original sources and official health guidance for more details. Sources: Key information has been drawn from Reuters, AP News, FDA/CDC releases, and expert commentary to ensure accuracy and timeliness reuters.com reuters.com reuters.com thewellnews.com reuters.com
25 August 2025
 ·  ·  ·  · 
Breakthrough Cures, Billion-Dollar Bets & Health Shockers – Global Biotech & Health News Roundup (Aug 23–24, 2025)

Breakthrough Cures, Billion-Dollar Bets & Health Shockers – Global Biotech & Health News Roundup (Aug 23–24, 2025)

Regulatory Approvals & Clinical Milestones Pharma & Biotech Industry Moves Startups & Innovation Highlights ([…Placeholder – if needed, otherwise this section can be omitted due to a lack of specific startup news on Aug 23–24 beyond the AI deal covered above.]) (The content above demonstrates how startup news might be presented. If no significant startup news occurred on Aug 23–24 beyond what’s covered in other sections, this section can be brief or omitted.) Medical Research & Innovation Public Health & Policy Developments Sources: FDA and company announcements via Reuters reuters.com reuters.com reuters.com reuters.com; FiercePharma and Reuters on industry moves reuters.com
24 August 2025
 ·  ·  ·  ·  ·  ·  ·  · 
Breakthrough Drugs, Big Deals & Public Health Alerts – Biotech and Health News Roundup (Aug 22–23, 2025)

Breakthrough Drugs, Big Deals & Public Health Alerts – Biotech and Health News Roundup (Aug 22–23, 2025)

Regulatory Approvals & Clinical Milestones Pharma & Biotech Industry Moves Startups & Innovation Highlights Medical Research & Innovation Public Health & Policy Developments Sources: Ionis HAE drug approval pharmexec.com biopharmadive.com; BioPharmaDive on Dawnzera pricing and positioning biopharmadive.com biopharmadive.com; AbbVie Rinvoq AA trial via FiercePharma fiercepharma.com; Lancet Neurology SAPPHIRE trial results neurologylive.com neurologylive.com; Reuters – Kite/Gilead’s Interius acquisition reuters.com and Interius press release interiusbio.com; PharmExec on XOMA-Mural deal ts2.tech; Reuters – J&J $2B NC facility and quote ts2.tech ts2.tech; Reuters – Apollo Hospitals stake sale ts2.tech; BiopharmaTrend on Kyorin adopting Elix AI platform biopharmatrend.com biopharmatrend.com; Laotian Times – Amgen Golden Ticket
23 August 2025
 ·  ·  ·  ·  ·  ·  ·  ·  · 
Global Biotech & Health Roundup: Breakthrough Drugs, Big Deals & Policy Shifts (Aug 21–22, 2025)

Global Biotech & Health Roundup: Breakthrough Drugs, Big Deals & Policy Shifts (Aug 21–22, 2025)

Pharmaceutical Industry News (Approvals, Trials & Deals) Biotech Startups & Funding Highlights Medical Research Breakthroughs & Publications Healthcare Policy & Public Health Developments Regulatory Updates from Agencies (FDA, EMA, etc.) Sources: Scientific press releases, company announcements, major news outlets (Reuters, AP, HealthDay, FierceBiotech, etc.), and health agency briefs were used to compile this report reuters.com reuters.com ts2.tech interiusbio.com. Each item includes a citation link to the original source for further reading. This concludes the comprehensive roundup of biotech, pharma, medical, and health news from August 21–22, 2025.
22 August 2025
 ·  ·  ·  ·  ·  ·  ·  ·  · 
Biotech Breakthroughs & Pharma Shakeups – Global Health Roundup (Aug 20–21, 2025)

Biotech Breakthroughs & Pharma Shakeups – Global Health Roundup (Aug 20–21, 2025)

Industry & Corporate Developments Mergers, Acquisitions & Partnerships Regulatory & Drug Approval Updates Public Health & Policy Research & Clinical Breakthroughs Sources: Reuters, Politico, HealthLeaders, BioPharma Dive, FierceBiotech, Pharmaceutical Executive, Technology Networks, McGill University reuters.com reuters.com healthleadersmedia.com reuters.com fiercebiotech.com reuters.com reuters.com technologynetworks.com technologynetworks.com.
21 August 2025
 ·  ·  ·  ·  ·  ·  ·  ·  ·  · 
Biotech, Pharma, and Health Breakthroughs You Missed on August 17–18, 2025

Biotech, Pharma, and Health Breakthroughs You Missed on August 17–18, 2025

New Drug Approvals & Clinical Trial Results Mergers, Acquisitions & Partnerships (No other major M&A deals were announced during Aug 17–18, but this Lilly-Superluminal alliance highlights the continued investment in AI-driven R&D.) Regulatory & Policy Updates Public Health & Epidemiology (No major new COVID-19 variant or pandemic threat emerged over the weekend, but health officials continue to monitor familiar foes like measles, polio, and others as vaccination lapses threaten to reverse public health gains.) Scientific & Medical Breakthroughs (Additional notable research: Other studies this week reported that a simple walking gait adjustment can ease knee arthritis as much as medication,
18 August 2025
 ·  ·  ·  ·  ·  ·  ·  ·  · 
Tech Titans Face Off, Rockets Soar, and Biotech Breakthroughs – Tech News Roundup (Aug 17–18, 2025)

Tech Titans Face Off, Rockets Soar, and Biotech Breakthroughs – Tech News Roundup (Aug 17–18, 2025)

Smartphones & Gadgets: Pixel Teasers and iPhone Rumors Cybersecurity: Telecom Ransomware Shock Space & Aerospace: Record Launches and New Missions Biotech & Health Tech: New Cures and Big Deals Tech Policy & Regulation: Trade Tensions and Antitrust Fines Autos & Mobility: Carmaker Alliances and EV Moves Sources: Reuters, Spaceflight Now, TechRadar, PhoneArena, MacRumors, TS2 Technology techradar.com techradar.com reuters.com reuters.com reuters.com cybernewscentre.com cybernewscentre.com ts2.tech ts2.tech, et al.
18 August 2025
 ·  ·  ·  · 
Breakthrough Cures, Big Deals, and Global Health Alerts – Biotech & Health News Roundup (Aug 16–17, 2025)

Breakthrough Cures, Big Deals, and Global Health Alerts – Biotech & Health News Roundup (Aug 16–17, 2025)

For the period August 16–17, 2025, the biotech, pharma, medical, and health sectors saw a range of significant developments worldwide. Below is a comprehensive roundup of top stories categorized by theme, complete with expert insights and source links: Clinical Trial Results & Study Readouts Drug & Device Approvals Mergers, Acquisitions & Partnerships Public Health Alerts Research & Medical Breakthroughs Healthcare Policy & Industry Trends Each news item above includes direct source references for verification. This roundup spans clinical trial outcomes, drug approvals, industry deals, public health alerts, research breakthroughs, and policy updates from around the globe during August 16–17, 2025,
17 August 2025
 ·  ·  ·  · 
Cures, Cash & Controversy: Global Biotech & Health Roundup (Aug 14–15, 2025)

Cures, Cash & Controversy: Global Biotech & Health Roundup (Aug 14–15, 2025)

Breakthroughs in Biotech & Pharma Big Deals & Industry Moves Regulatory & Health Policy Updates Public Health Developments Noteworthy Medical Research Healthcare Technology & Innovation Sources: Original news reports, press releases and scientific publications from Aug 14–15, 2025 fda.gov fiercebiotech.com fiercepharma.com paho.org fiercebiotech.com, as cited above. Each development is attributed to reputable sources including FDA announcements, company press statements, peer-reviewed journals, and expert commentary to ensure accuracy and context.
15 August 2025
 ·  ·  ·  ·  ·  ·  · 
Miracle Cure, Mega-Deals & Vaccine Drama: Global Biotech & Health Roundup (Aug 13–14, 2025)

Miracle Cure, Mega-Deals & Vaccine Drama: Global Biotech & Health Roundup (Aug 13–14, 2025)

Breakthroughs in Biotech & Pharma Big Deals & Industry Moves Regulatory & Health Policy Updates Public Health Developments Noteworthy Medical Research Healthcare Technology & Innovation Sources: Official press releases, government health agency updates, and reputable media coverage were used in this report (including Reuters, Fierce Biotech/Pharma, Bloomberg, FDA/CDC/DSHS releases, and peer-reviewed journals). All source links are provided inline above for reference.
14 August 2025
 ·  ·  ·  ·  ·  ·  · 
Blockbuster Breakthroughs, Setbacks & Surges: Biotech and Health News Roundup (Aug 11–12, 2025)

Blockbuster Breakthroughs, Setbacks & Surges: Biotech and Health News Roundup (Aug 11–12, 2025)

IO Biotech’s Phase 3 melanoma vaccine Cylembia added to Merck’s Keytruda narrowly missed statistical significance, with median progression-free survival of 19.4 months versus 11 months for Keytruda alone. Fosun Pharma’s deal with Expedition Therapeutics grants rights outside Greater China to XH-S004, a first-in-class oral DPP-1 inhibitor for chronic respiratory diseases, in a pact potentially worth up to $645 million including $120 million upfront and up to $525 million in milestones. NextRNA Therapeutics announced on August 11 it is winding down operations after cash constraints, leaving about 27 employees. FDA approved ketamine (brand name KETARx) from PharmaTher Holdings for surgical anesthesia
12 August 2025
 ·  ·  ·  · 
1 … 4 5 6 7
Go toTop